SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Grever Michael R.)
 

Search: WFRF:(Grever Michael R.) > Zenz Thorsten > Consensus guideline...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Grever, Michael R. (author)
Ohio State University
Abdel-Wahab, Omar (author)
Memorial Sloan-Kettering Cancer Center
Andritsos, Leslie A. (author)
Ohio State University
show more...
Banerji, Versha (author)
University of Manitoba
Barrientos, Jacqueline (author)
Hofstra University
Blachly, James S. (author)
Ohio State University
Call, Timothy G. (author)
Mayo Clinic Minnesota
Catovsky, Daniel (author)
Institute of Cancer Research London
Dearden, Claire (author)
Royal Marsden Biomedical Research Centre
Demeter, Judit (author)
Semmelweis University
Else, Monica (author)
Institute of Cancer Research London
Forconi, Francesco (author)
University Hospital Southampton
Gozzetti, Alessandro (author)
Azienda Ospedaliera Universitaria Senese, Siena
Ho, Anthony D (author)
Heidelberg University
Johnston, James B. (author)
University of Manitoba
Jones, Jeffrey (author)
Ohio State University
Juliusson, Gunnar (author)
Lund University,Lunds universitet,Stamcellscentrum (SCC),Avdelningen för stamcellsforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,Stem Cell Center,Division of stem cell research,Department of Laboratory Medicine,Faculty of Medicine
Kraut, Eric (author)
Ohio State University
Kreitman, Robert J. (author)
National Cancer Institute, USA
Larratt, Loree (author)
University of Alberta
Lauria, Francesco (author)
Azienda Ospedaliera Universitaria Senese, Siena
Lozanski, Gerard (author)
Ohio State University
Montserrat, Emili (author)
University of Barcelona
Parikh, Sameer A. (author)
Mayo Clinic Minnesota
Park, Jae-Hyun (author)
Memorial Sloan-Kettering Cancer Center
Polliack, Aaron (author)
Hadassah University Hospital
Quest, Graeme R. (author)
University of Toronto
Rai, Kanti R. (author)
Hofstra University
Ravandi, Farhad (author)
University of Texas
Robak, Tadeusz (author)
Medical University of Lodz
Saven, Alan (author)
Scripps Clinic
Seymour, John F. (author)
Peter MacCallum Cancer Centre
Tadmor, Tamar (author)
Technion - Israel Institute of Technology
Tallman, Martin S. (author)
Memorial Sloan-Kettering Cancer Center
Tam, Constantine (author)
Peter MacCallum Cancer Centre
Tiacci, Enrico (author)
University of Perugia
Troussard, Xavier (author)
Centre Hospitalier Universitaire Côte de Nacre
Zent, Clive S. (author)
University of Rochester
Zenz, Thorsten (author)
German Cancer Research Centre
Zinzani, Pier-Luigi (author)
University of Bologna
Falini, Brunangelo (author)
University of Perugia
show less...
 (creator_code:org_t)
American Society of Hematology, 2017
2017
English 8 s.
In: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 129:5, s. 553-560
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Hairy cell leukemia is an uncommon hematologic malignancy characterized by pancytopenia and marked susceptibility to infection. Tremendous progress in the management of patients with this disease has resulted in high response rates and improved survival, yet relapse and an appropriate approach to retreatment present continuing areas for research. The disease and its effective treatment are associated with immunosuppression. Because more patients are being treated with alternative programs, comparison of results will require general agreement on definitions of response, relapse, and methods of determining minimal residual disease. The development of internationally accepted, reproducible criteria is of paramount importance in evaluating and comparing clinical trials to provide optimal care. Despite the success achieved in managing these patients, continued participation in available clinical trials in the firstline and particularly in the relapse setting is highly recommended. The Hairy Cell Leukemia Foundation convened an international conference to provide common definitions and structure to guide current management. There is substantial opportunity for continued research in this disease. In addition to the importance of optimizing the prevention and management of the serious risk of infection, organized evaluations of minimal residual disease and treatment at relapse offer ample opportunities for clinical research. Finally, a scholarly evaluation of quality of life in the increasing number of survivors of this now manageable chronic illness merits further study. The development of consensus guidelines for this disease offers a framework for continued enhancement of the outcome for patients.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Publication and Content Type

for (subject category)
ref (subject category)

Find in a library

  • Blood (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view